Thomas Cluzeau

31PUBLICATIONS
207CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersLiquid biopsiesMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

|Jun 23, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Jul 14, 2025
Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with <i>TP53</i> mutant MDS/AML.

David A Sallman, Rami S Komrokji, Amy E Dezern

Pageof 6

Frequent Collaborators

6 joint publications

Christian Recher

6 joint publications

Rami S Komrokji

6 joint publications

Lionel Adès

5 joint publications

David A Sallman